Project BioShield
Project BioShield

Author: Frank Gottron

Publisher: DIANE Publishing

Published: 2010

Total Pages: 13

ISBN-13: 1437922848

DOWNLOAD EBOOK

Contents: (1) Introduction; (2) The Project BioShield Act: Expedited Procedures; Market Guarantee; Emergency Use of Unapproved Products; Reporting Requirements; (3) Appropriations; (4) Acquisitions; (5) Policy Issues; Diversion of Appropriations for Other Purposes; Transfer of Account to HHS; Stockpile Replenishment; Broad Spectrum Countermeasures; The Biomedical Advanced Research and Development Authority. Charts and tables.

Project BioShield
Project BioShield

Author: Frank Gottron

Publisher: DIANE Publishing

Published: 2010-11

Total Pages: 18

ISBN-13: 143793692X

DOWNLOAD EBOOK

Many potential chemical, biological, radiological, and nuclear (CBRN) terrorism agents lack medical counter-measures. The Project BioShield Act (PBA) became law in 2004 to address this need. Contents of this report: (1) Intro.; (2) The PBA: Expedited Procedures; Market Guarantee; Emergency Use of Unapproved Products; Reporting Requirements; (3) Appropriations; (4) Acquisitions; (5) BioShield and the Biodefense Advanced R&D Authority; (6) Policy Issues: Diversion of BioShield Funds to Other Purposes: Transfers for CBRN Countermeasure R&D; Transfer for Pandemic Influenza Preparedness; Changing the Counter-measure Development and Acquisition Process; Stockpile Management; Broad-Spectrum Countermeasures. Illus.

Project BioShield Act
Project BioShield Act

Author: Cynthia A. Bascetta

Publisher: DIANE Publishing

Published: 2010

Total Pages: 33

ISBN-13: 1437920713

DOWNLOAD EBOOK

This report formally transmits the briefing in response to section 247d-6c of title 42 of the United States Code. The statute required the Comptroller General to examine the Department of Health and Human Services' (HHS) support for the development and procurement of and authority for the emergency use of medical countermeasures to address chemical, biological, radiological, and nuclear threats to public health, and provide the results to the congressional committees by July 21, 2009. HHS determines priorities for medical countermeasure procurement based on those chemical, biological, radiological, and nuclear agents that have been identified by the Department of Homeland Security (DHS) as posing a material threat to the U.S. population that could affect national security. Tables.

Renewing the Project BioShield Act
Renewing the Project BioShield Act

Author: Robert Kadlec

Publisher:

Published: 2013

Total Pages: 16

ISBN-13:

DOWNLOAD EBOOK

In the next several months, the president and members of Congress will decide whether to continue the funding and authorities associated with Project BioShield, which seeks to expand the U.S. stockpile of medical countermeasures for potential chemical, biological, radiological and nuclear attacks. In this report Dr. Robert Kadlec writes that Project BioShield has achieved its strategic objectives and merits continued support and funding. He argues that the president and Congress should affirm its value as a critical insurance policy against the risk of these types of attacks.

Crossing the Valley of Death
Crossing the Valley of Death

Author: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Bioterrorism and Public Health Preparedness

Publisher:

Published: 2005

Total Pages: 64

ISBN-13:

DOWNLOAD EBOOK

The Project BioShield Act
The Project BioShield Act

Author: Frank Gottron

Publisher:

Published: 2012

Total Pages: 17

ISBN-13:

DOWNLOAD EBOOK

In 2004, Congress passed the Project BioShield Act (P.L. 108-276) to provide the federal government with new authorities related to the development, procurement, and use of medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) terrorism agents. As the expiration of some of these authorities approaches, Congress is considering whether these authorities have sufficiently contributed to national preparedness to merit extension. The 112th Congress is considering several Project BioShield-related policy questions. One question is whether the Project BioShield acquisition mechanism has sufficiently improved national preparedness relative to its costs to merit extension. If so, congressional policymakers may consider whether changes to the funding levels or how Congress provides Project BioShield funds would improve the program's efficiency or performance. Additionally, congressional policymakers are considering whether the federal government sufficiently plans and coordinates its CBRN countermeasure efforts from basic research to distribution. Finally, Congress is considering whether changes to the emergency use authority will improve preparedness and planning.